- Home
- CGTX vs QSI Comparison
CGTX vs QSI Comparison
Compare CGTX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- QSI
- Stock Information
- Founded
- CGTX 2007
- QSI 2013
- Country
- CGTX United States
- QSI United States
- Employees
- CGTX N/A
- QSI N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- CGTX Health Care
- QSI Health Care
- Exchange
- CGTX Nasdaq
- QSI Nasdaq
- Market Cap
- CGTX 79.3M
- QSI 94.1M
- IPO Year
- CGTX 2021
- QSI N/A
- Fundamental
- Price
- CGTX $0.44
- QSI $1.21
- Analyst Decision
- CGTX Buy
- QSI Buy
- Analyst Count
- CGTX 6
- QSI 2
- Target Price
- CGTX $8.00
- QSI $2.50
- AVG Volume (30 Days)
- CGTX 476.7K
- QSI 15.7M
- Earning Date
- CGTX 11-13-2024
- QSI 11-12-2024
- Dividend Yield
- CGTX N/A
- QSI N/A
- EPS Growth
- CGTX N/A
- QSI N/A
- EPS
- CGTX N/A
- QSI N/A
- Revenue
- CGTX N/A
- QSI $2,266,000.00
- Revenue This Year
- CGTX N/A
- QSI $270.89
- Revenue Next Year
- CGTX N/A
- QSI $214.75
- P/E Ratio
- CGTX N/A
- QSI N/A
- Revenue Growth
- CGTX N/A
- QSI 232.26
- 52 Week Low
- CGTX $0.34
- QSI $0.61
- 52 Week High
- CGTX $2.95
- QSI $2.43
- Technical
- Relative Strength Index (RSI)
- CGTX 41.17
- QSI 63.06
- Support Level
- CGTX $0.43
- QSI $0.61
- Resistance Level
- CGTX $0.48
- QSI $1.89
- Average True Range (ATR)
- CGTX 0.04
- QSI 0.13
- MACD
- CGTX -0.01
- QSI 0.04
- Stochastic Oscillator
- CGTX 7.26
- QSI 46.79
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.